| 3-FMA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 4-MMC | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 8-Chlorotheophylline | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Adrafinil | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Atropa belladonna | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| Benzydamine | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| Bromantane | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Cake | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Datura | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| Deschloroetizolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Desomorphine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Dichloropane | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Diclazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Diphenhydramine | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| Ephedrine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Eszopiclone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Etizolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flubromazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flubromazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flunitrazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flunitrazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Gaboxadol | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Hexedrone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Lorazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Mephenaqualone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Methcathinone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Metizolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Midazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Naloxone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Nicotine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Nifoxipam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Opioids | Dangerous | — |
| Oxiracetam | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Pentobarbital | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Phenobarbital | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Phenylpiracetam | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Rhodiola Rosea | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| SAMe | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Alcohol | Unsafe | — |
| 1,3-Butanediol | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 25E-NBOH | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 2C-T | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 2C-T-2 | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 2C-T-21 | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 2C-T-7 | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 3-Cl-PCP | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 3-HO-PCE | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 3-HO-PCP | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 3-MeO-PCE | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 3-MeO-PCMo | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 3-MeO-PCP | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 4-MeO-PCP | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Allylescaline | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Ayahuasca | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Deschloroketamine | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| DET | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Diphenidine | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| DiPT | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| DOM | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| DPT | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Efavirenz | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Ephenidine | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| EPT | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| HXE | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Ibogaine | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Inhalants | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Memantine | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| MET | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Methallylescaline | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| MiPT | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| MPT | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| MXiPr | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| O-PCE | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| PCE | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| Psilocybin Mushrooms | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |